NEW YORK (dpa-AFX) - The US analyst firm Bernstein Research has upgraded its rating for Evonik to "Outperform" with a target price of 21 euros after the annual results. The key figures of the specialty chemicals group gave shareholders little reason to be happy, wrote analyst Gunther Zechmann in a study published on Monday. However, the first quarter had apparently started very well and the assumptions underlying the outlook for 2024 were conservative, he added./edh/gl

Publication of the original study: 04.03.2024 / 06:45 / UTC First distribution of the original study: 04.03.2024 / 06:45 / UTC

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------